Cargando…

Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI

The medium‐dose etoposide (VP16) added on cyclophosphamide (CY)/total body irradiation (TBI) is one of the intensified myeloablative conditioning regimens used in allogenic hematopoietic stem cell transplantation (allo‐HSCT) for acute lymphoblastic leukemia (ALL). However, the patient subgroups who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morita‐Fujita, Mari, Arai, Yasuyuki, Kondo, Tadakazu, Harada, Kaito, Uchida, Naoyuki, Toya, Takashi, Ozawa, Yukiyasu, Fukuda, Takahiro, Ota, Shuichi, Onizuka, Makoto, Kanda, Yoshinobu, Maruyama, Yumiko, Takada, Satoru, Kawakita, Toshiro, Ara, Takahide, Ichinohe, Tatsuo, Kimura, Takafumi, Atsuta, Yoshiko, Kako, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084153/ https://www.ncbi.nlm.nih.gov/pubmed/35790020 http://dx.doi.org/10.1002/hon.3046

Ejemplares similares

Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)

A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)

Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2019)

Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
por: Iwasaki, Makoto, et al.
Publicado: (2022)

P1306: IMPACT OF HLA DISPARITY ON THE RISK OF OVERALL MORTALITY IN PATIENTS WITH EXTENSIVE CHRONIC GVHD
por: Fuji, Shigeo, et al.
Publicado: (2023)

Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan
por: Shimomura, Yoshimitsu, et al.
Publicado: (2022)

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia
por: Konuma, Takaaki, et al.
Publicado: (2022)

Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
por: Araie, Hiroaki, et al.
Publicado: (2023)

Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy
por: Arai, Yasuyuki, et al.
Publicado: (2015)

Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group
por: Kimura, Shun-ichi, et al.
Publicado: (2023)

P1323: THE PROGNOSIS AND COMPLICATIONS OF PATIENTS WITH PRE-TRANSPLANT LIVER DYSFUNCTION
por: Misaki, Yukiko, et al.
Publicado: (2023)

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2023)

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades
por: Nishiwaki, Satoshi, et al.
Publicado: (2022)

Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10)
por: Mizumaki, Hiroki, et al.
Publicado: (2022)

Novel risk assessment for the intensity of conditioning regimen in older patients
por: Akahoshi, Yu, et al.
Publicado: (2022)

Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation
por: Tamaki, Masaharu, et al.
Publicado: (2023)

P1261: NEGATIVE IMPACT OF HLA-B LEADER MISMATCH ON OUTCOMES OF HCT WITH PTCY FOR LYMPHOID MALIGNANCIES: A RETROSPECTIVE ANALYSIS FROM THE JAPANESE SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY
por: Kanaya, Minoru, et al.
Publicado: (2023)

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome
por: Maeda, Yoshinobu, et al.
Publicado: (2019)

Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
por: Tamaki, Masaharu, et al.
Publicado: (2022)

Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?
por: Konuma, Takaaki, et al.
Publicado: (2023)

P1265: UNRELATED FEMALE-TO-MALE BONE MARROW TRANSPLANTATION SHOULD BE PREFERRED OVER CORD BLOOD TRANSPLANTATION IN MALE RECIPIENTS.
por: Tamaki, Masaharu, et al.
Publicado: (2023)

Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol
por: Terakura, Seitaro, et al.
Publicado: (2020)

A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
por: Shigematsu, Akio, et al.
Publicado: (2015)

Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis
por: Kurosawa, Shuhei, et al.
Publicado: (2021)

Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
por: Takamatsu, Hiroyuki, et al.
Publicado: (2023)

Personalized prediction of overall survival in patients with AML in non‐complete remission undergoing allo‐HCT
por: Hirabayashi, Shigeki, et al.
Publicado: (2021)

Signal stability of Cy3 and Cy5 on antibody microarrays
por: Gu, Qiang, et al.
Publicado: (2006)

CyTOF(®) for the Masses
por: Iyer, Akshay, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
por: Murata, Makoto, et al.
Publicado: (2020)

A highly fluorescent DNA toolkit: synthesis and properties of oligonucleotides containing new Cy3, Cy5 and Cy3B monomers
por: Hall, Lucy M., et al.
Publicado: (2012)

CyDNA: Synthesis and Replication of Highly Cy-Dye Substituted DNA by an Evolved Polymerase
por: Ramsay, Nicola, et al.
Publicado: (2010)

Sequence-Dependent Fluorescence of Cy3- and Cy5-Labeled Double-Stranded DNA
por: Kretschy, Nicole, et al.
Publicado: (2016)

Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin
por: Kanda, Junya, et al.
Publicado: (2020)

Hospitals and the Doctrine of "Cy-Pres"
Publicado: (1910)

Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program
por: Kanda, Yoshinobu, et al.
Publicado: (2022)

Graft-versus-MDS effect after unrelated cord blood transplantation: a retrospective analysis of 752 patients registered at the Japanese Data Center for Hematopoietic Cell Transplantation
por: Ishiyama, Ken, et al.
Publicado: (2019)

Sequence-dependence of Cy3 and Cy5 dyes in 3ʹ terminally-labeled single-stranded DNA
por: Kekić, Tadija, et al.
Publicado: (2022)

MIM-CyCIF: Masked Imaging Modeling for Enhancing Cyclic Immunofluorescence (CyCIF) with Panel Reduction and Imputation
por: Sims, Zachary, et al.
Publicado: (2023)

MIM-CyCIF: Masked Imaging Modeling for Enhancing Cyclic Immunofluorescence (CyCIF) with Panel Reduction and Imputation
por: Chang, Young Hwan, et al.
Publicado: (2023)

COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI)
por: Smith, Douglas H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v5rg3j3uqlgtenot5k0jpi134f